PPVT SS showed a trend towards a significant association with plasma cholesterol level (Spearman’s rho = −0.45, p = 0.07; corrected p = 0.086) but a nonsignificant association with CSF cholesterol level (Spearman’s rho = −0.32; p = 0.21; corrected p = 0.23).
These studies showed a trend towards increased plaque size in thoracic-abdominal aortas of Cx47 -/- Apoe -/- mice ( Fig 10A , p = 0.07).
S-1-based regimens showed a trend toward a higher ORR than capecitabine, with a pooled risk ratio of 1.14 (95% CI: 0.99-1.32; p = 0.07), though this difference did not reach statistical significance.
Results Cognitive dysfunction was detected in 9 (24%) CDC patients and 6 (14%) OC patients by Mini Mental State Exam (MMSE) corrected for educational level. Independent predictors of abnormal MMSE (p<0.05) included stroke history (OR=5.51; 95% CI=1.27–24.01) and digoxin use (OR=0.23, 95% CI=0.06–0.89), while CD showed a trend toward statistical significance (OR=4.63; 95% CI=0.87–24.73, p= 0.07).
Fasting showed a trend toward age‐dependent effects on plasma TG concentrations based on the age × fasting interaction ( F 2,37 = 3.0, P < 0.07).
The analysis by Duncan’s test showed that animals in 3 rd month of life showed a trend increase in the Avoidance 1 (p = 0.070) compared to animals in 1 st month.
would they be less satisfied if the animals demonstrated more indicators of poor welfare on their farms? For fattening pigs there was no significant difference in the numbers of pigs between satisfied and dissatisfied farmers, but when farmers were satisfied with conditions, unexpectedly, the prevalences of body lesions and lameness showed a trend to be higher ( P = 0.07 and 0.10 respectively).
In an additional questionnaire, patients in the Decalogue group showed a trend towards a better understanding of their state of health ( p = 0.07).
NAC mice showed a trend for improvement in comparison to PBS-treated mice ( p = 0.07; Fig. 8 a).
In our study, although F 0 did not differ between the two conditions, some individuals showed a trend towards a clinically relevant decrease in their F 0 production with the NAS in a single day (e.g. −0.18 to −0.36 N.kg − 1 ; p < 0.07).
Position showed a trend toward a response compatibility-like effect with faster responses to left-sided targets, χ 2 (1, N = 20) = 3.26, p = 0.07.
A post-hoc comparison of the group exposed to clean air and the group exposed to fear chemosignals showed a trend level time x odour interaction during the second day of trial (F(1,45)=3.74, p=0.07).
Greater fear of a negative outcome predicted greater likelihood of delay (Wald = 6.29, p = .012), and screening embarrassment showed a trend in the same direction (Wald = 3.28, p = .070).
miR-143/145 +/− marrows also showed a trend toward reduced LT-HSC ( P = 0.07). miR-143/145 −/− and miR-143/145 +/− mice had similar marrow cellularity to WT mice suggesting a deficit in absolute number of HSC (Fig. 1b ).
Similarly, patients presenting the highest angiogenin levels presented a normal MRC score at 6 months ( p = 0.043; Figure 4D ) and functional outcomes assessed by the Rankin scale also showed a trend toward better improvement at 1 month ( p = 0.07; Figure 4E ), showing the association between high angiogenin levels and better neurological improvements.
The secondary endpoints, progression-free survival and AML-free survival were also investigated and showed a trend to a more favorable outcome for patients with elevated HbF: the median progression-free survival was 7.7 months versus 2.4 months (HR=0.32; 95% CI: 0.10–1.10; P =0.07) ( Figure 3B ) and the median AML-free survival was 13.1 months versus 7.6 months (HR=0.42; 95% CI: 0.13–1.38; P =0.15) ( Figure 3C ).
Patients with high Lu/BCAM expression showed a trend toward larger tumor size ( p = 0.07) and lower disease-specific survival ( p = 0.08), although not reaching statistical significance.
Nutrition-related behavioral measures An eating disorder diagnosis based on the eating disorder questionnaire at age 20 showed a trend for higher prevalence in those with AIS compared with those without (25.0% vs 11.1%; p = .07), but this trend was not seen at younger ages ( Table 3 ).
In patients with residual disease, gains in ER protein positivity following neoadjuvant therapy were associated with enhanced disease‐free survival (DFS) (Gain HR = 0.37, 95% CI = 0.14‐0.99, P < 0.05) (Figure 1L ) and showed a trend toward an association with overall survival (OS) (Gain HR = 0.40, 95% CI = 0.15‐1.10, P < 0.07, Supplementary Figure S6A ).
The interim overall survival (OS) analysis showed a trend favoring apalutamide, as the median OS was 39 months in the placebo arm and was not reached in the apalutamide arm; HR = 0.70, p = 0.07.
The order CW040 (phylum TM7, previously shown in ruminal contents of dairy heifers, [ 25 ]) again showed a trend for significance between RFI groups ( p = 0.07) ( Supplementary Table S4 ).
However, forty-eight weeks after surgery, the cell-T group showed a trend for a greater KOOS QOL score compared with the control group (79.4 vs. 39.1, respectively; P=0.07).
ADC max only showed a trend towards lower values for HPV positive OPC (p=0.07).
Prednisolone showed a trend toward a benefit in the relapsed subgroup ( P = .070).
Cyclic ADTHAV showed a trend of higher activity in delivering IgG mAb compared to linear ADTHAV ( p = 0.07), whereas there was no significant difference between cyclic ADTHAV and ADTC5 ( p = 0.20).